In this study we demonstrate that the transverse relaxation rate R2* affords a biomarker of response to a potent anaplastic lymphoma kinase inhibitor in the Th-ALKF1174L/Th-MYCN genetically engineered murine model of neuroblastoma, a childhood cancer of the nervous system
This abstract and the presentation materials are available to members only; a login is required.